tryptamine-4,5-dione has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Crino, PB; Fishman, J; Rubins, J; Schenepper, PW; Vogt, BA; Volicer, L; Wolfe, N | 1 |
1 review(s) available for tryptamine-4,5-dione and Alzheimer Disease
| Article | Year |
|---|---|
Neurotoxic properties of a serotonin oxidation product: possible role in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Indolequinones; Oxidation-Reduction; Rats; Serotonin; Tryptamines | 1989 |